With continual advances in treatment, more people with cystic fibrosis (CF) are surviving well into adulthood and by 2040,…
Marisa Wexler, MS
Marisa holds a Master of Science in cellular and molecular pathology from the University of Pittsburgh, where she studied novel genetic drivers of ovarian cancer. Her areas of expertise include cancer biology, immunology, and genetics, and she has worked as a science writing and communications intern for the Genetics Society of America.
At Bionews we’re committed to providing the most accurate, relevant, and up-to-date reporting for our patient communities. Our goal is to ensure that everyone has access to disease-specific information that is both trustworthy and easy to understand. You can read more about our editorial policy here.
Articles by Marisa Wexler, MS
Women and girls with cystic fibrosis (CF) who are being treated with antibiotics due to a pulmonary exacerbation tend…
CFTR modulators, a highly effective therapy for cystic fibrosis (CF), do not appear to affect fertility outcomes for men using them, data…
Note: This story was updated Nov. 9 to note that experiments done with Sionna’s CFTR modulators used a different investigational…
Exposure to tobacco smoke may reduce the effectiveness of Kalydeco (ivacaftor), a CFTR modulator that is widely approved to…
A novel scoring system may be used to classify the severity of lung disease among children with cystic fibrosis…
Women with cystic fibrosis (CF) have different experiences with sexual and reproductive health than their peers without the disease,…
The overall protein profile in the airway is altered toward a more pro-inflammatory state in people with cystic fibrosis…
A novel gene-editing treatment platform corrected the mutation that causes cystic fibrosis (CF) in multiple tissues throughout the bodies of…
Anemia is common among lung transplant recipients, and people with cystic fibrosis (CF) are at more than four times…